Management of inflammatory bowel disease in the elderly: A review
- PMID: 36681569
- DOI: 10.1016/j.dld.2022.12.024
Management of inflammatory bowel disease in the elderly: A review
Abstract
The burden of Inflammatory Bowel Disease (IBD) is increasing worldwide, with a particular increase in the prevalence in the elderly population, due to the ageing of young-onset IBD as well as to the increasing incidence in elderly patients. Elderly IBD patients present specific challenges to the treating physician, as they have comorbidities, lower functional reserves, and higher risk of treatment-related complications. The diagnosis of IBD in the elderly may be difficult due to a more subtle disease presentation and to a wide range of differential diagnosis. Moreover, as these patients are often excluded from clinical trials, there is a lack of high-quality evidence to inform on the most appropriate management. Despite an increasing prevalence, the management of IBD in the elderly is still hindered by frequent misconceptions by physicians treating these patients. Due to a erroneous notion of a milder disease course and fear of adverse events, elderly IBD-patients are managed with frequent and continuous use of steroids and undertreated with effective medical therapies. In this review, we describe the principles of management of IBD in the elderly, which is a topic of increasing importance to IBD clinics, that will have to progressively adapt to care for an ageing population.
Keywords: Crohn's disease; Frailty; Ulcerative colitis.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest to declare.
Similar articles
-
[Treatment of Inflammatory Bowel Disease in Elderly Patients - What Are Different and What Should We Know?].Korean J Gastroenterol. 2021 May 25;77(5):231-240. doi: 10.4166/kjg.2021.077. Korean J Gastroenterol. 2021. PMID: 34035201 Review. Korean.
-
IBD in the Elderly: Management Challenges and Therapeutic Considerations.Curr Gastroenterol Rep. 2019 Nov 27;21(11):60. doi: 10.1007/s11894-019-0720-7. Curr Gastroenterol Rep. 2019. PMID: 31776797 Review.
-
Inflammatory bowel disease and the elderly: a review.J Crohns Colitis. 2015 Jun;9(6):507-15. doi: 10.1093/ecco-jcc/jjv059. Epub 2015 Apr 13. J Crohns Colitis. 2015. PMID: 25870198 Review.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294385 Free PMC article.
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294382 Free PMC article.
Cited by
-
Choosing Therapies in Ulcerative Colitis.J Can Assoc Gastroenterol. 2023 Sep 4;7(1):9-21. doi: 10.1093/jcag/gwad025. eCollection 2024 Feb. J Can Assoc Gastroenterol. 2023. PMID: 38314181 Free PMC article.
-
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence.Biomedicines. 2023 Jun 4;11(6):1633. doi: 10.3390/biomedicines11061633. Biomedicines. 2023. PMID: 37371728 Free PMC article. Review.
-
Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system.Front Pharmacol. 2025 Feb 11;16:1436183. doi: 10.3389/fphar.2025.1436183. eCollection 2025. Front Pharmacol. 2025. PMID: 40008128 Free PMC article.
-
Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a meta-analysis on a global scale.J Health Popul Nutr. 2025 Apr 9;44(1):112. doi: 10.1186/s41043-025-00860-z. J Health Popul Nutr. 2025. PMID: 40205601 Free PMC article.
-
Advanced Therapies in Elderly Patients With Inflammatory Bowel Disease: A Comparative Retrospective Cohort Study in Taiwan.Ther Clin Risk Manag. 2025 Apr 25;21:533-542. doi: 10.2147/TCRM.S518405. eCollection 2025. Ther Clin Risk Manag. 2025. PMID: 40303313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical